UPDATED RESULTS FROM THE HGB-206 STUDY IN PATIENTS WITH SEVERE SICKLE CELL DISEASE TREATED UNDER A REVISED PROTOCOL WITH LENTIGLOBIN GENE THERAPY USING PLERIXAFOR-MOBILISED HAEMATOPOIETIC STEM CELLS

EHA Library, Julie Kanter, 267387

TARGETING THE IMMUNOPHILIN FKBP12 BY DRUG REPURPOSING OR RNASE-BASED APPROACHES FOR BMP-SMAD PATHWAY AND HEPCIDIN UPREGULATION IN HEREDITARY HEMOCHROMATOSIS

EHA Library, Mariateresa Pettinato, 267382

INTESTINAL MICROBIOTA CAN PREDICT AGVHD FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lijie Han, 267377

TISAGENLECLEUCEL APPEARS EFFECTIVE AND SAFE IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA WITH HIGH-RISK CYTOGENETIC ABNORMALITIES

EHA Library, Stephan A. Grupp, 267372

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION CAN ABROGATE INCREASING RISK OF RELAPSE FROM PERSISTENT MUTATIONS MEASURED BY TARGETED SEQUENCING AT REMISSION IN NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA

EHA Library, Taehyung Kim, 267367

RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA: RESULTS FROM THE MPNSG-0212 COMBINATION TRIAL (NCT01644110)

EHA Library, Frank Stegelmann, 267362

FIRST CLINICAL (PHASE 1B/2A) STUDY OF IBERDOMIDE (CC-220; IBER), A CELMOD, IN COMBINATION WITH DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Sagar Lonial, 267357

BASELINE TOTAL METABOLIC TUMOR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL

EHA Library, Marek Trneny, 267352

DEVELOPMENT OF A CLINICAL PREDICTION RULE FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Alejandro Lazo-Langner, 267396

A BAL-DRIVEN ANTIMICROBIAL TREATMENT IMPROVES CLINICAL OUTCOME IN HEMATOLOGIC MALIGNANCIES PATIENTS WITH LUNG INFILTRATES DETECTION: A PROSPECTIVE MULTICENTER STUDY OF THE SEIFEM GROUP

EHA Library, Francesco Marchesi, 267391

SAFETY AND EFFICACY OF LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSAEMIA AND NON-B0/B0 GENOTYPES IN THE PHASE 3 NORTHSTAR-2 STUDY

EHA Library, Franco Locatelli, 267386

THE HEMOCHROMATOSIS PROTEINS HJV AND TFR2 ARE DISPENSABLE FOR ACUTE BMP2-MEDIATED HEPCIDIN UPREGULATION IN MICE

EHA Library, Alessia Pagani, 267381

TANDEM AUTOLOGOUS-REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN HIGH-RISK RELAPSED HODGKIN LYMPHOMA: A RETROSPECTIVE STUDY OF THE LWP-EBMT

EHA Library, Leyre Bento de Miguel, 267376

A DASATINIB-BLINATUMOMAB COMBINATION FOR THE FRONT-LINE TREATMENT OF ADULT PH+ ALL PATIENTS. PRELIMINARY RESULTS OF THE GIMEMA LAL2116 D-ALBA TRIAL; ON BEHALF OF GIMEMA ACUTE LEUKEMIA WORKING PARTY

EHA Library, Sabina Chiaretti, 267371

MOLECULAR MRD STATUS AND OUTCOME AFTER TRANSPLANTATION IN NPM1 MUTATED AML: RESULTS FROM THE UK NCRI AML17 STUDY

EHA Library, Dillon RICHARD, 267366

MOLECULAR ANALYSIS IN MAJIC PV CORRELATION WITH CLINICAL ENDPOINTS.

EHA Library, Natalia Curto-Garcia, 267361

CARFILZOMIB AND DEXAMETHASONE MAINTENANCE PROLONG TIME TO PROGRESSION FOLLOWING SALVAGE ASCT IN MULTIPLE MYELOMA: A RANDOMIZED PHASE 2 TRIAL BY THE NORDIC MYELOMA STUDY GROUP

EHA Library, Henrik Gregersen, 267356

PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) : THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL)

EHA Library, Monica Balzarotti, 267351

Management of pregnant women with inherited platelet defect

EHA Library, Patrizia Noris, 274209

Neonatal leukemia

EHA Library, Irene Roberts, 274206

From intracellular antibodies to antibody derived compounds targeting oncogenic proteins in leukemia

EHA Library, Terry Rabbitts, 274205

Impact of stigma on psychosocial aspects of sickle cell disease

EHA Library, Kofi Anie, 273547

CD19 MUTATION FREQUENCY AFTER BLINATUMOMAB TREATMENT IS LOWER THAN AFTER CAR T-CELLS TREATMENT

EHA Library, Michaela Kotrová, 267243

SAFETY AND EFFICACY OF TISAGENLECLEUCEL (CTL019) IN B ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND YOUNG ADULTS: ROBERT DEBRÉ AND SAINT LOUIS HOSPITALS EXPERIENCE

EHA Library, Andre Baruchel, 267244

LONG-TERM OUTCOME OF ALLOGENEIC-HCT IN ADULT PATIENTS WITH ALL IN FIRST REMISSION; FAVORABLE GVHD-AND-RELAPSE-FREE SURVIVAL OF DOUBLE CORD BLOOD TRANSPLANTATION COMPARED TO CONVENTIONAL DONOR TYPES

EHA Library, Joonyeop Lee, 267245

KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: END OF PHASE 1 RESULTS OF ZUMA-3

EHA Library, Bijal D. Shah, 267246

BLINATUMOMAB + PONATINIB FOR RELAPSED PH1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: THE FRENCH EXPERIENCE.

EHA Library, Marie-Anne COUTURIER, 267247

THE SUCCESSFUL APPLICATION OF ANTI-CD19 CAR-T THERAPY TO PATIENTS WITH CENTRAL NERVE SYSTEM B-CELL ACUTE LYMPHOCYTIC LEUKEMIA

EHA Library, Liyun Chen, 267248

EXCELLENT RESPONSE TO BLINATUMOMAB IN REFRACTORY B LINEAGE ACUTE LYMPHOBLASTIC LEUKAEMIA IN CHILDREN AND YOUNG ADULTS AFTER DEBULKING CHEMOTHERAPY TO ACHIEVE PARTIAL REMISSION.

EHA Library, Katherine Clesham, 267249

INOTUZUMAB OZOGAMICIN (INO) TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA (R/R ALL): OUTCOMES OF PATIENTS TREATED IN SALVAGE ONE WITH A LONG DURATION OF FIRST REMISSION

EHA Library, Matthias Stelljes, 267250

EFFICACY AND SAFETY OF INOTUZUMAB OZOGAMICIN IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED IN THE INO-VATE TRIAL: OUTCOMES BY SALVAGE-TREATMENT PHASE

EHA Library, Elias Jabbour, 267251

MORE OR LESS? IMPACT OF DOSE NUMBER ON OUTCOMES OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH INOTUZUMAB OZOGAMICIN

EHA Library, David I Marks, 267252

NELARABINE AS SALVAGE THERAPY FOR PEDIATRIC PATIENTS WITH RELAPSED T-ALL

EHA Library, Luciana Vinti, 267253

SURVIVAL OUTCOME OF SECOND ALLOGENEIC-HCT IN ADULT ALL PATIENTS WHO RELAPSED AFTER PREVIOUS ALLOGENEIC-HCT

EHA Library, Seug Yun Yoon, 267254

TIME FROM RANDOMIZATION TO FIRST SUBSEQUENT INDUCTION/SALVAGE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH INOTUZUMAB OZOGAMICIN IN THE PHASE 3 INO-VATE TRIAL

EHA Library, Elias Jabbour, 267255

FEASIBLE OUTCOME OF BLINATUMOMAB FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULTS WITH RELAPSED OR REFRACTORY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, JAE HO YOON, 267256

A MULTICENTER, RETROSPECTIVE STUDY TO EVALUATE EFFICACY AND SAFETY OF BUSULFAN/FLUDARABINE CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Seung-Shin Lee, 267257

INITIAL SAFETY AND EFFICACY OF LAROTRECTINIB IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): DATA FROM AN EXPANDED ACCESS PROGRAM

EHA Library, Denis Schewe, 267258

IMPROVING THE SAFETY OF CAR-T CELL THERAPY BY CONTROLLING CRS-RELATED COAGULOPATHY

EHA Library, Heng Mei, 267259

MVP COMBINED WITH FC AS LYMPHOCYTE-DEPLETING CHEMOTHERAPY BEFORE CAR-T TREATMENT CAN REDUCE THE INCIDENCE OF SEVERE CYTOKINE RELEASE SYNDROME FOR R/R ALL PATIENTS WITH HIGH TUMOUR BURDEN

EHA Library, Xiaowen Tang, 267260

BLINATUMOMAB - BASED THERAPIES IN CHILDREN AND ADULTS WITH MRD+ AND R/R B-ALL, EXPERIENCE FROM A SINGLE CENTER (CIC 725)

EHA Library, Inna Markova, 267261

PATIENTS WITH RELAPSED MIXED PHENOTYPE ACUTE LEUKEMIA HAVE SHORT REMISSION DURATION WITH RE-INDUCTION: A SINGLE CENTER EXPERIENCE

EHA Library, Claire Andrews, 267262

PHASE 1 RESULTS OF ZUMA-4: KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alan S. Wayne, 267263

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: DOES MINIMAL RESIDUAL DISEASE BEFORE TRANSPLANTATION MATTER FOR LONG TERM OUTCOME?

EHA Library, Ángela Figuera Álvarez, 267264

COMPARISON OF CONDITIONING REGIMEN CONTAINING TOTAL BODY IRRADIATION OR NOT FOR AUTOLOGOUS TRANSPLANTATION IN ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Zoufang Huang, 267265

A NOVEL FAST CD19 CAR-T CELLS: RAPID AND EFFICIENT TREATMENT FOR REFRACTORY B-ALL(BP-CML)

EHA Library, Xi Zhang, 267266

FUNCTIONAL COOPERATION OF CEBPA AND TET2 MUTATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Elizabeth Heyes, 267267

PRECLINICAL ACTIVITY OF THE NOVEL ORAL DUAL BET-CBP/P300 INHIBITORS, NEO1132 AND NEO2734, IN ACUTE MYELOID LEUKEMIA

EHA Library, Linda Smit, 267268

GENETIC LANDSCAPE OF FLT3-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS TREATED WITHIN THE RATIFY TRIAL: CALGB 10603 (ALLIANCE)

EHA Library, Nikolaus Jahn, 267269

HYPOMETHYLATING DRUGS SPECIFICALLY TARGET DNMT3A MUTATION ASSOCIATED CLONAL HEMATOPOIESIS AND ACUTE MYELOID LEUKEMIA

EHA Library, Marina Scheller-Wendorff, 267270

ESTIMATING LIFE-YEAR LOSS OF LOWER-RISK MYELODYSPLASTIC SYNDROMES IN EUROPE

EHA Library, Zhiyi Li, 267120

AT1413 ANTIBODY DERIVED FROM A CURED AML PATIENT RECOGNIZES A UNIQUE CD43 EPITOPE SHARED BY AML, MDS AND MELANOMA AND HAS IN VIVO ACTIVITY AS UNMODIFIED ANTIBODY AND AS BISPECIFIC T CELL ENGAGER

EHA Library, Greta de Jong, 267272

THE AML SECRETOME AND T CELL FUNCTION: MODULATION OF AMG 330-MEDIATED T CELL PROLIFERATION AND CYTOTOXICITY

EHA Library, Anna Maier, 267273

BCL-XL AS A PUTATIVE THERAPY TARGET IN ACUTE ERYTHROID LEUKEMIA

EHA Library, Heikki Kuusanmäki, 267274

MODELING NKG2D-BASED CAR-T CELL THERAPY IN ANIMALS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Martina Fontaine, 267275

HIGH-RESOLUTION CLONAL ANALYSIS OF TUMORS WITH SIMULTANEOUS SINGLE-CELL DNA SEQUENCING AND CELL SURFACE PHENOTYPING

EHA Library, G Fuerte, 267276

METABOLIC REPROGRAMMING OF ACUTE MYELOID LEUKEMIA STEM- PROGENITOR CELLS AT RELAPSE

EHA Library, Martina Ghetti, 267277

DISCOVERY OF NOVEL C/D BOX SNORNAS THAT ARE REQUIRED FOR LEUKEMIA CELL PROLIFERATION

EHA Library, Andreas Kienast, 267279

PI3K INHIBITION COMBINED WITH STANDARD CHEMOTHERAPY EFFECTIVELY INHIBITS KIT MUTANT AML

EHA Library, Montserrat Estruch, 267280

GRIK5 DRIVES SELF RENEWAL PATHWAYS IN HUMAN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Jianglong Xia, 267281

LONG TERM AML SURVIVORS HAVE INCREASED MORTALITY AND HIGH PREVALENCE OF CLONAL HEMATOPOIESIS

EHA Library, Noa Chapal Ilani, 267282

THE ROLE OF STAT3 ISOFORMS IN ACUTE MYELOID LEUKEMIA

EHA Library, Dagmar Stoiber, 267283

NOVEL MOLECULAR PATHOGENESIS AND THERAPEUTIC TARGET IN ACUTE ERYTHROID LEUKEMIA

EHA Library, June Takeda, 267284

CANNABINOIDS EXERT A POTENT ANTI-LEUKEMIC EFFECT AFFECTING SIGNALING PATHWAYS INVOLVED IN TUMOR CELL METABOLISM.

EHA Library, Mayte Medrano, 267285

SYK-DEPENDENT P-STAT5 ACTIVITY IS REQUIRED TO MAINTAIN CLONOGENIC POTENTIAL AND OXPHOS METABOLISM IN ACUTE MYELOID LEUKEMIA (AML) CELLS

EHA Library, Anna Polak, 267287

RIBOMETHYLOME CHANGES DEPEND ON DISTINCT PATTERNS OF C/D BOX SNORNAS IN AML SUBTPYES

EHA Library, Christian Rohde, 267288

CHARACTERIZATION OF A NOVEL, POTENT SMALL MOLECULE MDM2 ANTAGONIST WHICH ACTIVATES WILD-TYPE P53 AND INDUCES APOPTOSIS IN AML

EHA Library, Nicola Ferrari, 267289

ABNORMAL DNA METHYLATION MODIFIES HOX GENES EXPRESSION IN BONE MARROW MESENCHYMAL STROMAL CELLS OF MYELODYSPLASIAS AND DE NOVO ACUTE MYELOID LEUKEMIAS

EHA Library, Benjamin Roux, 267290

INTEGRATED ANALYSIS OF NTAL RELATED GENES IMPROVES OUTCOMES PREDICTION OF EUROPEAN LEUKEMIANET 2008 RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Diego Antonio Pereira-Martins, 267291

CA-4948, AN IRAK4/FLT3 INHIBITOR, SHOWS ANTILEUKEMIC ACTIVITY IN MOUSE MODELS OF FLT3 WILD-TYPE AND FLT3 MUTATED ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Robert Booher, 267292

MSI2 REGULATES BACH1/BRIP1 THUS AFFECTING THE OXIDATIVE STRESS RESPONSE

EHA Library, Jessica Hoell, 267293

DE NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS DISPLAY AT DIAGNOSIS FUNCTIONAL DEREGULATION OF REDOX BALANCE CORRELATED WITH MOLECULAR SUBTYPES AND OVERALL SURVIVAL

EHA Library, Julie Mondet, 267294

OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA (O-CMML) SHARES IMMUNOPHENOTYPIC AND MOLECULAR CHARACTERISTICS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

EHA Library, Xavier Calvo, 267295

IMPACT OF DNMT3A MUTATIONAL STATUS IN MOLECULAR MEASURABLE RESIDUAL DISEASE CLEARANCE IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1

EHA Library, Guadalupe Oñate, 267296

TCF4 IS IMPORTANT FOR MUTANT RUNX1-MEDIATED CELL IMMORTALIZATION AND PREDICTS OUTCOME IN ACUTE MYELOID LEUKEMIA

EHA Library, Florentien In 'T Hout, 267297

A NEW BIOMARKER OF RESPONSE TO 5-AZACITIDINE THERAPY IN MDS AND AML PATIENTS: SIRPB1

EHA Library, Claudio Cerchione, 267298

JANUS KINASE AND CYTOKINE RECEPTOR MUTATIONS IN TRANSIENT ABNORMAL MYELOPOIESIS AND MYELOID LEUKEMIA IN CHILDREN WITH TRISOMY 21

EHA Library, Leila Varghese, 267299

SINGLE CELL SIGNALING PHARMACODYNAMICS IN A PHASE 1B CLINICAL TRIAL OF THE AXL INHIBITOR BEMCENTINIB IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Oda Helen Eck Fagerholt, 267300

ANTI-CD19 CAR-T THERAPY BRIDGING TO ALLO-HSCT IMPROVES LONG-TERM OUTCOME OF B-ALL PATIENTS WITH HIGH LEUKEMIA BURDEN OR POOR PROGNOSTIC MARKERS

EHA Library, Heng Mei, 267242

COMBINATION BCL-2 INHIBITOR THERAPY WITH VENETOCLAX AND NAVITOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOBLASTIC LYMPHOMA

EHA Library, Vinod A. Pullarkat, 267241

CAR-T CELL THERAPY BRIDGING TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION LED TO SUPERIOR SURVIVAL FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS OUT OF REMISSION

EHA Library, Xiaohui Hu, 267240

INTENSIVE PAEDIATRIC THERAPY IS AS DELIVERABLE IN ADOLESCENTS AND YOUNG ADULTS AS CHILDREN WITH ALL - PRELIMINARY RESULTS OF THE AUSTRALASIAN LEUKAEMIA AND LYMPHOMA GROUP (ALLG) ALL06 STUDY

EHA Library, Matthew GREENWOOD, 267239

RANDOMIZED PHASE III HOVON-100 STUDY OF CLOFARABINE COMBINED WITH STANDARD TREATMENT IN ADULT PATIENTS WITH NEWLY DIAGNOSED ALL

EHA Library, Anita Rijneveld, 267238

APPLICABILITY OF DROPLET DIGITAL PCR (DDPCR) FOR MINIMAL RESIDUAL DISEASE MONITORING (MRD) IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sabina Chiaretti, 267236

NOVEL PHARMACOGENOMIC AND PHARMACOTRANSCRIPTOMIC MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Vladimir Gašić, 267235

DISCOVERING PATHWAYS INVOLVED IN RESISTANCE TO INDUCTION THERAPY IN T-ALL TO TREAT REFRACTORY AND RELAPSED DISEASE

EHA Library, Melanie Beckett, 267234

HIV INTEGRASE INHIBITOR MK-2048 INDUCES APOPTOSIS IN HTLV-1 INFECTED CELLS THROUGH THE UPR ACTIVATION.

EHA Library, Emi Ikebe, 267233

ADULT TRIPLE NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA FUSION DETECTION: CHALLENGING AIM FOR PH- ALTERNATIVE THERAPIES

EHA Library, Anna Ferrari, 267232

PARTICIPATION IN A SPECIALISED EXERCISE INTERVENTION IMPROVED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH HAEMATOLOGICAL CANCERS

EHA Library, Jennifer Nicol, 267131

ESTIMATING LIFE-YEAR LOSS OF PRIMARY MYELOFIBROSIS IN EUROPE

EHA Library, Zhiyi Li, 267130

THE DIAGNOSTIC YIELD OF BONE MARROW BIOPSY IN PATIENTS WITH LIVER FAILURE

EHA Library, Thinzar Ko Ko, 267129

THE FINANCIAL IMPACT OF ACUTE LEUKAEMIA

EHA Library, Charlotte Martin, 267128

FLUPENTIXOL MELITRACEN COMBINED WITH ONDANSETRON IN PREVENTION OF NAUSEA AND VOMITING INDUCED BY CONDITIONING IN PATIENT TO UNDERGO HSCT

EHA Library, Ying Lu, 267127

QUALITY OF LIFE IN PATIENTS WITH RRMM DURING IXA-THAL-DEX INDUCTION AND IXAZOMIB MAINTENANCE THERAPY IN COMPARISON TO THE GENERAL POPULATION

EHA Library, Heinz Ludwig, 267126

QUALITY OF LIFE AND PERCEPTION OF HEALTH CARE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN THE UK

EHA Library, Esther Oliva, 267125

INCREASED VOC FREQUENCY ASSOCIATED WITH REDUCED HRQOL AMONG PATIENTS WITH SCD

EHA Library, Miranda Bailey, 267124

APREPITANT AS ADJUNCT FOR THE MANAGEMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS WITH HEMATOLOGIC MALIGNANCY UNDERGOING HIGHLY EMETOGENIC CHEMOTHERAPY: A META-ANALYSIS

EHA Library, Feroni Pella Panjaitan, 267123

CLINICAL AND ECONOMIC BURDEN OF MYELOFIBROSIS IN A LARGE US MANAGED CARE POPULATION

EHA Library, Kejal Parikh, 267122

ASSESSMENT OF HM-PRO ITALIAN VERSION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES IN CLINICAL PRACTICE

EHA Library, Esther Oliva, 267121

ACUTE MYELOID LEUKEMIA CELLS ARE DEPENDENT ON S100A4 FOR GROWTH AND SURVIVAL

EHA Library, Bader Alanazi, 267271